StockData
TELA Bio, Inc. logo

TELA Bio, Inc. (TELA) stock

TELANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$0.78+0.02 (+2.36%)

Close on Nov 18, 2026Market cap $35.02MP/E –Yield –

TELA Bio operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

TELA Bio's operating cash flow for the twelve months ending Jun 30, 2026 was -$31.14M. For fiscal 2025 it was -$28.22M. The highest annual figure on record is -$16.37M in fiscal 2017.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$28.22M–
FY2024Dec 31, 2024-$41.60M–
FY2023Dec 31, 2023-$40.86M–
FY2022Dec 31, 2022-$40.75M–
FY2021Dec 31, 2021-$30.43M–
FY2020Dec 31, 2020-$24.46M–
FY2019Dec 31, 2019-$25.52M–
FY2018Dec 31, 2018-$19.92M–
FY2017Dec 31, 2017-$16.37M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$9.38M–
Q1 FY2026Mar 31, 2026-$11.17M–
Q4 FY2025Dec 31, 2025-$4.87M–
Q3 FY2025Sep 30, 2025-$5.72M–
Q2 FY2025Jun 30, 2025-$7.91M–
Q1 FY2025Mar 31, 2025-$9.73M–
Q4 FY2024Dec 31, 2024-$7.53M–
Q3 FY2024Sep 30, 2024-$8.98M–
Q2 FY2024Jun 30, 2024-$10.70M–
Q1 FY2024Mar 31, 2024-$14.38M–
Q4 FY2023Dec 31, 2023-$11.05M–
Q3 FY2023Sep 30, 2023-$6.97M–
Q2 FY2023Jun 30, 2023-$11.26M–
Q1 FY2023Mar 31, 2023-$11.57M–
Q4 FY2022Dec 31, 2022-$10.98M–
Q3 FY2022Sep 30, 2022-$7.65M–
Q2 FY2022Jun 30, 2022-$11.69M–
Q1 FY2022Mar 31, 2022-$10.43M–
Q4 FY2021Dec 31, 2021-$9.59M–
Q3 FY2021Sep 30, 2021-$6.63M–
Q2 FY2021Jun 30, 2021-$5.63M–
Q1 FY2021Mar 31, 2021-$8.59M–
Q4 FY2020Dec 31, 2020-$7.10M–
Q3 FY2020Sep 30, 2020-$3.69M–
Q2 FY2020Jun 30, 2020-$6.36M–
Q1 FY2020Mar 31, 2020-$7.31M–
Q2 FY2019Jun 30, 2019-$5.21M–
Q1 FY2019Mar 31, 2019-$7.78M–
Q4 FY2018Dec 31, 2018-$5.76M–

More TELA Bio figures

See a number that looks wrong?